,,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu', 'bcsm', '$azn', 'astrazeneca', 'daiichi']
astrazeneca, daiichi s enhertu could transform breast cancer treatment with landmark her2-low show. how will enhertu change #breastcancer treatment for patients previously categorized as her2-negative? #asco22 #bcsm $azn
Actionable Strategies for Life Sciences